Zacks Investment Research on MSN

CHMP backs higher-dose Wegovy as Novo Nordisk seeks 2026 EU approval

Novo Nordisk NVO announced that the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) ...
Medical News Today

GLP-1s may have little to no impact on breast, thyroid cancer risk, research says

GLP-1s for weight loss may not affect the risk of obesity-related cancers either way, an analysis of the existing evidence ...